Agenus | Satış Brüt Kar



Gross Profit On Sales Değişiklik Tarih
AbbVie USD 10.71B 458M 2024-12
Amgen USD 5.54B 430M 2025-03
AstraZeneca USD 11.35B 819M 2025-03
Bristol-Myers Squibb USD 8.18B 947M 2025-03
Celldex Therapeutics 32.09M 32.23M 2024-09
CSL USD 4.28B 939M 2024-12
Dynavax Technologies USD 54.4M 4.23M 2025-03
Eli Lilly USD 10.5B 624.7M 2025-03
Gilead Sciences USD 5.99B 17M 2024-12
GlaxoSmithKline GBP 5.59B 34M 2025-03
Glaxosmithkline GBP 5.6B 94M 2024-12
Incyte USD 985.09M 111.22M 2025-03
J&J USD 14.6B 816M 2025-03
Jiangsu Hengrui CNY 6.08B 703.42M 2025-03
MacroGenics USD 13.86M 94.98M 2024-12
Merck EUR 3.14B 46M 2025-03
Merck USD 12.77B 849M 2025-03
Novartis USD 10.23B 294M 2024-12
Pfizer USD 11.12B 987M 2025-03
Regeneron Pharmaceuticals USD 2.56B 659.4M 2025-03
Veracyte USD 79.51M 754K 2025-03



Agenus Satış Brüt Kar - Akım değerleri, tarihsel veriler, tahminler, istatistikler, grafikler ve ekonomik takvim - Jul 2025.